Literature DB >> 23523847

The mystery of mismatch repair deficiency: lynch or lynch-like?

C Richard Boland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23523847      PMCID： PMC3647610          DOI： 10.1053/j.gastro.2013.03.014

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  15 in total

Review 1.  Microsatellite instability in colorectal cancer.

Authors:  C Richard Boland; Ajay Goel
Journal:  Gastroenterology       Date:  2010-06       Impact factor: 22.682

2.  Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors.

Authors:  Noralane M Lindor; Lawrence J Burgart; Olga Leontovich; Richard M Goldberg; Julie M Cunningham; Daniel J Sargent; Catherine Walsh-Vockley; Gloria M Petersen; Michael D Walsh; Barbara A Leggett; Joanne P Young; Melissa A Barker; Jeremy R Jass; John Hopper; Steve Gallinger; Bharati Bapat; Mark Redston; Stephen N Thibodeau
Journal:  J Clin Oncol       Date:  2002-02-15       Impact factor: 44.544

3.  Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression.

Authors:  W Dietmaier; S Wallinger; T Bocker; F Kullmann; R Fishel; J Rüschoff
Journal:  Cancer Res       Date:  1997-11-01       Impact factor: 12.701

Review 4.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

Authors:  C R Boland; S N Thibodeau; S R Hamilton; D Sidransky; J R Eshleman; R W Burt; S J Meltzer; M A Rodriguez-Bigas; R Fodde; G N Ranzani; S Srivastava
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

5.  Risk of cancer in cases of suspected lynch syndrome without germline mutation.

Authors:  María Rodríguez-Soler; Lucía Pérez-Carbonell; Carla Guarinos; Pedro Zapater; Adela Castillejo; Victor M Barberá; Miriam Juárez; Xavier Bessa; Rosa M Xicola; Juan Clofent; Luis Bujanda; Francesc Balaguer; Josep-Maria Reñé; Luisa de-Castro; José C Marín-Gabriel; Angel Lanas; Joaquín Cubiella; David Nicolás-Pérez; Alejandro Brea-Fernández; Sergi Castellví-Bel; Cristina Alenda; Clara Ruiz-Ponte; Angel Carracedo; Antoni Castells; Montserrat Andreu; Xavier Llor; José L Soto; Artemio Payá; Rodrigo Jover
Journal:  Gastroenterology       Date:  2013-01-24       Impact factor: 22.682

6.  Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1.

Authors:  Marjolijn J L Ligtenberg; Roland P Kuiper; Tsun Leung Chan; Monique Goossens; Konnie M Hebeda; Marsha Voorendt; Tracy Y H Lee; Danielle Bodmer; Eveline Hoenselaar; Sandra J B Hendriks-Cornelissen; Wai Yin Tsui; Chi Kwan Kong; Han G Brunner; Ad Geurts van Kessel; Siu Tsan Yuen; J Han J M van Krieken; Suet Yi Leung; Nicoline Hoogerbrugge
Journal:  Nat Genet       Date:  2008-12-21       Impact factor: 38.330

7.  Somatic mosaicism and double somatic hits can lead to MSI colorectal tumors.

Authors:  Isabelle Sourrouille; Florence Coulet; Jeremie H Lefevre; Chrystelle Colas; Mélanie Eyries; Magali Svrcek; Armelle Bardier-Dupas; Yann Parc; Florent Soubrier
Journal:  Fam Cancer       Date:  2013-03       Impact factor: 2.375

8.  Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry.

Authors:  Jinru Shia
Journal:  J Mol Diagn       Date:  2008-06-13       Impact factor: 5.568

Review 9.  EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome.

Authors:  Glenn E Palomaki; Monica R McClain; Stephanie Melillo; Heather L Hampel; Stephen N Thibodeau
Journal:  Genet Med       Date:  2009-01       Impact factor: 8.822

10.  Inactivation of promoter 1B of APC causes partial gene silencing: evidence for a significant role of the promoter in regulation and causative of familial adenomatous polyposis.

Authors:  A Rohlin; Y Engwall; K Fritzell; K Göransson; A Bergsten; Z Einbeigi; M Nilbert; P Karlsson; J Björk; M Nordling
Journal:  Oncogene       Date:  2011-06-06       Impact factor: 9.867
View more
  16 in total

1.  Screening adherence and cancer risk perceptions in colorectal cancer survivors with Lynch-like syndrome.

Authors:  L H Katz; A M Burton-Chase; S Advani; B Fellman; K M Polivka; Y Yuan; P M Lynch; S K Peterson
Journal:  Clin Genet       Date:  2015-09-14       Impact factor: 4.438

2.  Clinical characteristics of patients with colorectal cancer with double somatic mismatch repair mutations compared with Lynch syndrome.

Authors:  Rachel Pearlman; Sigurdis Haraldsdottir; Albert de la Chapelle; Jon G Jonasson; Sandya Liyanarachchi; Wendy L Frankel; Thorunn Rafnar; Kari Stefansson; Colin C Pritchard; Heather Hampel
Journal:  J Med Genet       Date:  2019-03-15       Impact factor: 6.318

3.  Cancer screening behaviors and risk perceptions among family members of colorectal cancer patients with unexplained mismatch repair deficiency.

Authors:  Lior H Katz; Shailesh Advani; Allison M Burton-Chase; Bryan Fellman; Katrina M Polivka; Ying Yuan; Patrick M Lynch; Susan K Peterson
Journal:  Fam Cancer       Date:  2017-04       Impact factor: 2.375

Review 4.  Laboratory Assays in Evaluation of Lynch Syndrome in Patients with Endometrial Carcinoma.

Authors:  Bojana Djordjevic; Russell R Broaddus
Journal:  Surg Pathol Clin       Date:  2016-04-11

5.  Constitutional mismatch repair deficiency and Lynch syndrome among consecutive Arab Bedouins with colorectal cancer in Israel.

Authors:  Naim Abu Freha; Yaara Leibovici Weissman; Alexander Fich; Inbal Barnes Kedar; Marisa Halpern; Ignacio Sztarkier; Doron M Behar; Orly Arbib Sneh; Alex Vilkin; Hagit N Baris; Rachel Gingold; Flavio Lejbkowicz; Yaron Niv; Yael Goldberg; Zohar Levi
Journal:  Fam Cancer       Date:  2018-01       Impact factor: 2.375

6.  Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.

Authors:  Daniel D Buchanan; Yen Y Tan; Michael D Walsh; Mark Clendenning; Alexander M Metcalf; Kaltin Ferguson; Sven T Arnold; Bryony A Thompson; Felicity A Lose; Michael T Parsons; Rhiannon J Walters; Sally-Ann Pearson; Margaret Cummings; Martin K Oehler; Penelope B Blomfield; Michael A Quinn; Judy A Kirk; Colin J Stewart; Andreas Obermair; Joanne P Young; Penelope M Webb; Amanda B Spurdle
Journal:  J Clin Oncol       Date:  2013-12-09       Impact factor: 44.544

7.  Differentiating Lynch-like from Lynch syndrome.

Authors:  John M Carethers
Journal:  Gastroenterology       Date:  2014-01-24       Impact factor: 22.682

8.  Outcomes of screening endometrial cancer patients for Lynch syndrome by patient-administered checklist.

Authors:  Molly S Daniels; Diana L Urbauer; Azadeh Zangeneh; Brittany A L Batte; Katherine M Dempsey; Karen H Lu
Journal:  Gynecol Oncol       Date:  2013-10-17       Impact factor: 5.482

Review 9.  Genetics, biomarkers, hereditary cancer syndrome diagnosis, heterogeneity and treatment: a review.

Authors:  Henry T Lynch; Kristen Drescher; Joseph Knezetic; Stephen Lanspa
Journal:  Curr Treat Options Oncol       Date:  2014-09

10.  Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations.

Authors:  Sigurdis Haraldsdottir; Heather Hampel; Jerneja Tomsic; Wendy L Frankel; Rachel Pearlman; Albert de la Chapelle; Colin C Pritchard
Journal:  Gastroenterology       Date:  2014-09-03       Impact factor: 22.682
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.